Healthcare Policy
Healthcare policy is never static. Federal and state governments set the rules, CMS interprets them, and private payers follow. For medical device and biopharmaceutical companies, policy shifts don't just create compliance challenges — they reshape reimbursement landscapes, affect long-term business planning, and ultimately determine whether patients can access the technologies they need.
We provide actionable intelligence on evolving healthcare policy and coverage changes so our clients can make informed strategic decisions — before change catches them off guard.
Our policy monitoring work is integrated directly into your market access and reimbursement strategy, ensuring that policy developments are translated into clear, business-relevant guidance your team can act on.
Policy Monitoring
Continuous tracking of federal and state policy developments, CMS rulemaking, and CPT editorial updates that directly affect your coverage and reimbursement position.
Policy Impact Assessments
Translating policy changes into clear, business-relevant implications for your technology, market access strategy, and long-term planning horizon.
CMS & Payer Policy Guidance
Interpreting coverage determinations, payment rules, and payer policy shifts across Medicare, Medicaid, and commercial markets.
Risk Identification & Mitigation
Identifying regulatory and reimbursement risks early — including coding definition changes and coverage policy gaps — and building strategies to address them proactively.
Stakeholder & Advocacy Insights
Understanding the policy positions of key stakeholders, specialty societies, trade associations, and advocacy organizations that influence coverage and payment decisions.
Stay ahead of the policy curve.
Let's talk about the policy landscape affecting your technology and how Prevara can help you navigate it strategically.
Get In Touch →